ROBIN GRIPADO: Open Payments
NPI 1508242975 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 31 payments from 9 companies in 2025. Trend: 2023 $933 · 2024 $210 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $326 |
| UCB, Inc. | 12 | $202 |
| ABBVIE INC. | 8 | $176 |
| TG Therapeutics, Inc. | 1 | $118 |
| EMD Serono, Inc. | 2 | $76 |
| SK Life Science, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Cala Health, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
Products named: BRIUMVI, NURTEC ODT, ZAVZPRET, Nayzilam, QULIPTA, UBRELVY, BOTOX, KESIMPTA.
Industry payments across OK — which companies pay providers there.
